Systemic complement activation with intravascularly administered cobra venom factor (CVF) or infusion of either zymosanactivated rabbit plasma or a fifth component of complement fragment with anaphylatoxin activity in the rabbit have not caused significant increases in bronchoalveolar lavage albumin in rabbits (Webster, R. O., G. L. Larsen, B. C. Mitchell, A. J. Goins, and P. M. Henson. 1982. Am. Rev. Respir. Dis. 125:335-340). To assess if another stimulus (hypoxia) acting in concert with complement activation can produce significant lung injury, rabbits were challenged with CVF alone, 10 min of 12% oxygen alone, or CVF followed by a 10-min exposure to 12% oxygen. Either stimulus alone caused no significant changes in arterial oxygen, pulmonary resistance, or dynamic compliance during the 240 min of observation after either stimulus, and neither stimulus alone caused increased albumin accumulation in bronchoalveolar lavage over a 30-min period at the end of the experiment. However, the combination of insults significantly altered arterial oxygen, pulmonary resistance, and dynamic compliance while also increasing albumin and neutrophils recovered by lavage. The increase in lavage albumin did not appear to be due to hemodynamic events in that the pulmonary artery pressure increased acutely after CVF infusion and again during the hypoxic exposure, but was normal when albumin accumulation in the lung was measured. Neutrophil depletion with nitrogen mustard abolished all of these changes induced by CVF plus hypoxia. In addition, meclofenamate pretreatment and infusion during the 4-h study abolished the increases in lavage albumin and neutrophils as well as the increase in pulmonary artery pressure after CVF. Meclofenamate pretreatment did not, however, block accumulation of albumin in the lung (interstitium). We conclude that complement activation, as an isolated event, will not cause a significant increase in lavage albumin in this model. However, combining complement activation with an episode of hypoxia will lead to an increase in lavage albumin that is dependent on the presence of neutrophils for its expression. Meclofenamate treatment will prevent increases in lavage albumin and neutrophils while not preventing albumin accumulation in the lung
Introduction
Some recent observations have led to the hypothesis that intravascular complement activation can lead to neutrophil sequestration in pulmonary vessels with subsequent lung injury. Craddock and co-workers (1) found uremic patients undergoing hemodialysis developed neutropenia and lung dysfunction. In sheep and rabbits, they demonstrated that plasma incubated with dialyzer cellophane produced neutropenia and hypoxemia when infused into the test animals, with pulmonary histology showing gross intravascular leukostasis. Analysis of the plasma demonstrated complement activation had occurred. Hammerschmidt and co-workers (2) reported that, in patients at risk for developing the adult respiratory distress syndrome, neutrophil-aggregating activity in the plasma correlated significantly with the development of this syndrome.
Complement fragments derived from the fifth component of complement, (C5)' have been implicated as being important in causing these observed changes in lung structure and function for several reasons. First, the phlogistic potential of both the C5 fragment with anaphylatoxin activity (C5a) and the C5 fragment formed by removal of the C-terminal arginine from C5a, in terms of producing neutrophil chemotaxis, enzyme release, and oxygen radical production, are well described (3, 4) . In addition, Sacks and co-workers (5) suggested that C5a-stimulated granulocytes can cause endothelial cell damage in vitro. Complement activation in an intrapulmonary but extravascular location has been noted by us (6) and others (7) (8) (9) to produce pulmonary inflammation. Thus, although the inflammatory potential of C5 fragments in vitro and in an intrapulmonary location is well-established, their role in producing significant lung injury in an intravascular location is more open to debate. Although Till and associates (10) have found complement activation with cobra venom factor (CVF) in rats leads to lung injury, we reported that, in a rabbit model, the infusion of rabbit C5a, zymosan-activated rabbit plasma, or CVF were insufficient stimuli to produce alterations in lavage protein (albumin) despite causing pulmonary leukocyte sequestration and migration of neutrophils into the airspaces of the lung (1 1).
The present study was undertaken to determine whether another stimulus in addition to complement activation could lead to significant lung injury. Wedmore and Williams (12) described increased vascular permeability in rabbit skin when chemotactic fragments were injected with prostaglandin E2, and we noted increased vascular permeability in the lung when complement activation with CVF was followed by infusion of prostaglandin E2 (13) . The possible additive effect of chemotactic fragments and vasodilator prostaglandins in causing increased injury in both the skin and lung, plus the observation of Said and co-workers (14) that hypoxia leads to prostaglandin synthesis, led to the current study where hypoxia was selected as the stimulus to combine with complement activation in an attempt to produce lung injury.
Methods
Animals. New Zealand white rabbits weighing 2.5-3.4 kg were used in the experiments. Experimental design. Rabbits were anesthetized with sodium methohexital (Eli Lilly & Co., Indianapolis, IN) and intubated with a cuffed endotracheal tube, which was secured into position with adhesive tape.
An esophogeal balloon was inserted for use in determination of pulmonary functions (see below). Once anesthetized, an indwelling catheter was placed in the femoral artery. Sterile, pyrogen-free saline was infused to maintain an open catheter as well as the rabbit's circulatory system in an isovolume state. Blood samples were serially removed via a three-way stopcock for blood gas determinations, leukocyte counts, and complement assays. In selected experiments, respiratory function was not assessed, but hemodynamic events were monitored (see below). For all experiments, body temperature was monitored rectally, and maintained at 39.4±0.20C by a heating pad placed under the rabbit.
After surgery, the endotracheal tube was attached to a size 00 pneumotach (Hewlett-Packard model 21069B, Palo Alto, CA), which was attached to a Harvard respirator (Harvard Apparatus Co., Inc., S. Natick, MA). The animals breathed either room air or 12% oxygen delivered by the small animal respirator. Anesthesia was maintained by intermittent slow infusions of sodium methohexital. After obtaining stable blood gas and pulmonary function baselines, or stable hemodynamic measurements when these variables were monitored, the rabbits were injected with the test stimulus via the marginal ear vein as a bolus. In all experiments, CVF (300 U) or saline was injected at the beginning of the experiments while the rabbits were ventilated with room air. If they were subjected to the 10-min exposure to 12% oxygen, this was done 10 min after the bolus of intravenous saline (control) or CVF. They breathed the hypoxic mixture through the ventilator by connecting a weather balloon filled with the hypoxic mixture to the intake portal of the ventilator. After the 10-min hypoxia exposure, they were ventilated with room air for the remainder of the experiment. Assessment of lung injury was through evaluation of lung function (blood gases, lung mechanics), analysis of bronchoalveolar lavage for cells, and radiolabeled albumin, and assessment of lung structure, as detailed below.
Measurements of pulmonary functions in rabbits. Arterial blood gases (the partial pressure of arterial oxygen [Pao2], the partial pressure of arterial carbon dioxide [Paco2] , and the hydrogen ion concentration [pH]) were measured on an ABL2 Acid Base Laboratory (Radiometer, Copenhagen) using heparinized blood, with correction for the body temperature of the rabbit.
As noted above, the intubated animal breathed room air or 12% oxygen delivered by the respirator through a pneumotach. 5-10 min before each measurement of lung function, three forced inflations of the lungs to two times the tidal volume were performed to establish a lung volume history (15 (21) . To accomplish this, a one-way valve with 10 ml of dead space was constructed so the rabbit could breathe room air and exhale into a collection bag. During a 2-min collection, simultaneous arterial and mixed venous blood samples were taken for measurement of the arteriovenous content difference for oxygen. Thermodilution cardiac output was measured during this period. Exhaled gas was measured for oxygen content by using a mass spectrometer (model 1100 Medical Gas Analyzer, PerkinElmer, Pomona, CA) and for volume. From these data, Fick and thermodilution cardiac outputs were determined. An excellent correlation was noted between the two (Worthen, G. S., unpublished observations). During experiments, pressure was measured continually and recorded at 5-10-min intervals while cardiac output was measured every 10-30 min.
Permeability changes in rabbit lungs. In initial experiments, permeability was assessed as previously outlined (1 1). 30 min before the rabbits were killed, they were injected intravenously with 10 ,g of '251-rabbit serum albumin (RSA), 0.3 jCi/ttg of protein in 1 ml of normal saline. At death, samples of blood and lavage fluids were obtained, and radioactivity was measured in a gamma scintillation counter (Beckman Instruments, Inc., Fullerton, CA). The data was expressed as the radioactivity (counts per minute) in 1 ml of lavage fluid divided by either the injected counts (counts per minute per milliliter/106 counts per minute of injected) or the radioactivity in 1 ml of plasma (lavage/plasma ratio of '251-RSA in counts per minute per milliliter of lavage/counts per minute per milliliter of plasma).
In subsequent experiments, a more detailed determination of permeability changes within the lung was employed using a modification of a gravimetric determination described by Pearce and associates (22) . For this method, 59Fe-labeled erythrocytes (RBC) were used as a marker of intravascular blood volume instead of hemoglobin as employed by Pearce et al. (22) . The details of in vivo labeling of RBC with this radiolabel are given below. In these experiments, 1251-RSA was injected as detailed above, i.e., 30 min before the death of the animal. In addition, the 59Fe-RBC were injected 15 min before death. Samples obtained at the end of the experiment included blood, lung (right upper lobe), and lavage for determination of radioactivity (12511 RSA and 59Fe-RBC) corrected for crossover. In addition, wet and dry weight of both lung and blood were determined. Values for lung weights (wet or dry) and lung albumin were computed by subtracting the contribution of lung blood to these values.
Serum albumin: preparation and radiolabeling. Rabbit albumin was isolated following TEAE-cellulose chromatography of rabbit C5 (23) . It was purified further by molecular sieving on Sephadex G-100. Protein purity was determined by SDS polyacrylamide gel electrophoresis. The serum albumin was kept in phosphate-buffered saline (pH 7.2) at concentrations of 15 mg of protein/ml and stored at -20'C.
The albumin was radiolabeled with carrier-free 125I by use of a glucose oxidase-lactoperoxidase procedure as described by the Bio-Rad Product Information Bulletin No. 1060 (Bio-Rad Laboratories, Richmond, CA).
59Fe-labeled RBC. An in vivo method of labeling RBC with 59Fe was employed as described by Kopaniak et al. (24) . Briefly, 300 MCi of [59Felferrous citrate (New England Nuclear, Boston, MA) was incubated with 5 ml of rabbit serum, and injected into the marginal ear vein of the rabbit to be used for in vivo labeling. The incorporation of 59Fe into RBC was monitored, and as in the study by Kopaniak et al., the number of free or plasma-associated counts 48-72 h after injection of the radiolabel remained <1% of the total counts in the blood with 99% localized in the RBC fraction. For experiments, -5 ml of anticoagulated blood (10 IU/ml of heparin) containing -6 X 106 cpm of the 59Fe-RBC was obtained from the donor rabbit, and after counting, was infused into the recipient rabbit's circulation. The radioactivity and weight of 1 ml of circulating blood was determined at the time of death of the animal under study. Preparation ofCVF. Cobra venom (Bioactive, Inc., Arlington, VA) was highly purified by DEAE-Sephadex chromatography as described by Cochrane and co-workers (25) . The CVF was then treated with pbromphenacyl bromide to remove any trace amounts of phospholipase A2 (26) . The biologic activity was hemolytically assayed (25) after which the CVF was stored at -20°C until used. The intravenous dose of CFV employed in these studies was not associated with hemolysis of RBC.
Rabbit C5 assays. Hemolytic titers of rabbit C5 were determined by using a microtiter assay adopted from the procedure and reagent preparation described by Giclas and associates (23) . Serum samples (25 ,l) were serially diluted twofold in glucose-gelatin veronal buffer (pH 7.35) after which 25 Ml of sheep erythrocytes (5 X 10'/ml) sensitized with antibody and incubated sequentially with complement components Cl, C4, C2, and C3 was added to each well. Then, 25 JAl of normal rabbit serum treated with 2 M potassium thiocyanate was added to each well. After incubation at 37°C for 60 min, the plates were centrifuged and the hemolytic endpoints were determined. The endpoint titer was the reciprocal of the highest dilution at which hemolysis occurred. The results are expressed as the percent of initial hemolytic titer.
Bronchoalveolar lavage. At death, the lungs of the rabbits killed with intravenously administered sodium methohexital were carefully removed. After tying off one upper lung lobe for counting, a polypropylene catheter was gently inserted into the left lower lobe. After securing the catheter distal to the carina with silk suture, 15 ml of sterile saline at 25°C was gently lavaged in and out of the lung a total of four times. This procedure routinely resulted in 10-12 ml of recovered volume. Recovered samples of <9 ml were not analyzed. The lavage samples were cooled to 3°C in wet ice after which the suspended cells were removed by centrifugation (300 g for 10 min).
The radioactivity of the supernatant fluid was determined as described above, whereas the cell pellet was resuspended in phosphate-buffered saline for total leukocyte and differential count.
Histologic and electron microscopic examination of the lung. After the lavage as described above, the lavaged lobe was tied off, and the remainder of the lung prepared for histologic and electron microscopic examination as previously described (6) . For this study, a Philips 400 T transmission electron microscope was used (Philips Electronic Instruments, Inc., Mahwah, NJ).
Neutrophil depletion. Rabbits were given 1.75 mg/kg intravenously of nitrogen mustard (Mustargen; Merck, Sharp & Dohme; West Point, PA). Serial blood counts with differentials were obtained daily to document neutrophil depletion, and the animals were studied 72 h after nitrogen mustard administration. To protect neutrophil-depleted animals from infection, the rabbits received a combination of procaine penicillin G and dihydrostreptomycin sulfate (Combiotic; Pfizer Inc., New York, NY) at the time of nitrogen mustard administration and daily until studied. In addition, to prevent dehydration, rabbits received intravenous fluids 24 and 48 h after the initial nitrogen mustard infusion.
Blood cell counts. Counts of circulating leukocytes were performed in duplicate using a Coulter model ZBI counter (Coulter Electronics, Inc., Hialeah, FL). Differential counts were made on air-dried microscope slide smears stained with Wright's stain. Neutrophil counts were expressed as percent of the initial (baseline) value.
Sodium meclofenamate studies. Sodium meclofenamate monohydrate provided by Dr. Martin L. Black of Warner-Lambert Company (Ann Arbor, MI) was dissolved in sterile saline at a concentration of 1 mg/mi. Rabbits given the drug received 10 mg/kg intravenously over a 30-min period before CVF administration, and an additional 3 mg/ kg. h by continuous infusion over the remainder of the experiment.
Statistical analysis. Data were analyzed with the t test for paired or unpaired data. The P value had to be <0.05 using a two-tailed test for the results to be considered statistically significant (27) . In addition, the coefficient of correlation was computed for several variables with testing of the deviation of r from 0, or no correlation, by use of the t test as outlined by Swinscow (28) .
Results
Effect of CVF on circulating complement and neutrophil concentrations. Intravascular injection of 300 U of CVF either alone or combined with hypoxia induced a decrease in hemolytic C5 concentrations, with presumed concomitant generation of O~a, to an average of <10% of the initial value. As shown in a previous study ( 11) , this degree of activity remained for the duration of the 4-h experiment. Exposure of the animals to 12% oxygen for a 10-min period alone did not lead to a decrease in hemolytic C5 concentrations.
The effect of the CVF, with or without hypoxia, on circulating neutrophils was to cause a rapid neutropenia followed by a neutrophilia. As shown previously ( 11) the neutropenia occurred within 5 min of the bolus injection of CVF, led to virtual absence of neutrophils in the peripheral circulation, and was followed by a recovery of circulating neutrophils to levels above baseline by 2-4 h. No consistent changes in neutrophil number were seen in the animals subjected to hypoxia without CVF.
Effect of CVF and hypoxia on blood gases and pulmonary function. Fig. 1 shows the changes in arterial oxygen in rabbits treated with CVF alone, hypoxia alone, or CVF plus hypoxia. Before challenge, the mean Pao2 in all three groups was normal without significant differences between groups. As displayed in the figure, the mean decrease in Pao2 during the exposure to 12% oxygen was -40 torr (mean Pao2±SEM = 34.7±1.1). Upon returning to breathing room air, the oxygen tension of the hypoxia alone group returned to baseline values, and throughout the remainder 6f the study, did not decrease significantly from baseline values. The group receiving CVF . Change in Pao2 (mean±SEM) in rabbits treated with CVF alone at time 0, hypoxia alone, or CVF followed by hypoxia. n = 5, 6, and 9 for each group, respectively. The latter group exhibited significant differences from the response in the groups treated with either stimulus alone.
alone also showed no significant changes from prechallenge values, or difference from the response to hypoxia. However, significant decreases in blood gas tensions were noted at 30, 120, and 240 min in the group subjected to both CVF and hypoxia when compared with the animals treated with CVF alone. At all time points from 30 min on, the response to hypoxia alone was significantly different from the response to CVF plus hypoxia. Whereas the magnitude of the drop in Pao2 in the latter group was not marked, the mean Pao2 never reached baseline values during the period of study. Fig. 2 shows changes in RL and Cd,, for the three study groups. Again, baseline lung function was not significantly different between groups, but statistically significant differences in response to these stimuli were noted between the three groups. The animals exposed to both CVF and hypoxia had the most marked changes. Abnormalities were most pronounced at 120 min when a mean increase in the RL to 145% of the baseline value had occurred while Cdyfl at this same time point had fallen to 59% of the baseline value (P < 0.01).
Effect of CVF with and without hypoxia on lung injury as assessed by lavage. As outlined in a previous study (1 1), the rabbits used for these experiments normally have <1% neutrophils in the cells recovered by pulmonary lavage. As shown in Table I , the rabbits that undergo anesthesia, intubation, and the surgical procedures described above and then receive intravenous saline (control) at the start of the experiment had a slight increase in lavageable neutrophils after 4 h of study (1.3±0.6%, mean±SEM). If 300 U of CVF was given intravenously to rabbits, the percentage increased to a mean of 7.8%, but as noted below, this was not accompanied by an increase in lavageable albumin. When the animals were subjected to 10 min of 12% oxygen alone, and were killed and lavaged 4 h later, the percent neutrophils increased to 4.2±1.3% (P < 0.05 vs. saline control). When the 300 U of CVF was followed 10 min after the infusion by 10 min of 12% oxygen, the percent neutrophils in the 14 animals studied increased to 11.2%±1.9% (P < 0.01 vs. saline control). Permeability in the lungs of the animals to radiolabeled albumin was determined by assessing the radioactivity present in the lavage both 1 and 4 h after challenge. The radiolabel was injected 30 min before the animal was killed so that the measured permeability to albumin across the alveolar-capillary membrane was limited to that 30-min period alone. In this way, the period under study was not one in which hemodynamic changes were occurring that could influence the interpretation of the data (see below). As shown in Fig. 3 , after CVF or hypoxia alone, the mean permeability as expressed by the lavage/plasma ratio for '251I-RSA was not significantly elevated when compared with the control experiments where saline was given. In addition, combining the CVF and hypoxia did not increase lavageable albumin at an early time point (1 h). On the other hand, 4 h after the combination of CVF plus hypoxia, increased values for permeability over a wide range were noted (P < 0.01 for all groups compared with CVF/hypoxia group).
Effect of neutrophil depletion on pulmonary changes produced by CVF and hypoxia. On the day that the animals treated 72 h earlier with nitrogen mustard were studied, two of the four animals had no neutrophils observed on peripheral blood counts and the two remaining animals had <500 neutrophils/mm3. Normally, the mean neutrophil count is -2,500/mm3. The mean hematocrit was 40% with the mean lymphocyte and platelet counts being 1,200/mm3 and 273,000/ Radiolabeled albumin in lavage expressed as a ratio to plasma albumin (counts per minute per milliliter of lavage/counts per minute per milliliter of plasma) in animals treated with normal saline (NS) alone (controls), CVF alone, hypoxia alone, or the combination of CVF/hypoxia. The radiolabel was injected 30 min before sacrifice of the animals whereas the CVF and hypoxia were given at the beginning of the experiments. Only the combination of CVF/ hypoxia led to significant increases in lavage albumin 4 h after challenge (P < 0.01 for CVF/hypoxia compared with all groups). Neutrophil depletion (-PMN) and meclofenamate treatment (Meclo) blocked the increased albumin accumulation seen with CVF/hypoxia. mm3, respectively. These values are normal for our laboratory except for the lymphocyte count, which averages -4,500/ mm3. 4 h after challenge with CVF and hypoxia, the mean percentage of neutrophils in the lavages was 1.1% (Table I) . The mean accumulation of albumin in the lavage was not elevated (Fig. 3) . No consistent changes in arterial oxygen occurred during the 4-h experiment, and mean Pao2 at 4 h was not decreased from baseline values. In addition, the mean RL for this experimental group was never >110.2% of the baseline value during the study while CdYn did not fall below 88%. Thus, neutrophil depletion prevented the increase in lavage neutrophils and albumin associated with CVF/hypoxia challenge as well as the physiologic alterations (increased RL, decreased Cdyn and Pao2) noted when neutrophils were present.
Effect of CVF plus hypoxia on lung albumin and blood. When both 125I-RSA and 59Fe-RBC were infused into animals, more extensive assessments of lung fluid, albumin, and blood could be performed. In particular, the wet/dry weights of bloodless lung, the lung extravascular water, the lung/plasma ratio of '25I-RSA (counts per minute per gram of dry bloodless lung/counts per minute per milliliter of plasma), and lung blood (gram of blood/gram of dry bloodless lung) were determined. While the mean values of both wet/dry weights of lung and extravascular water were greater in the CVF/hypoxiatreated rabbits than in the other groups, the differences were not statistically significant. In addition, the accumulation of albumin in the lavages did not correlate with either wet/dry weights or lung extravascular water. On the other hand, lavage~1 Lung/Plasma '251-RSA h before sacrifice or CVF/hypoxia I h before sacrifice (.), and rabbits receiving meclofenamate plus CVF/hypoxia 4 h before sacrifice (A). In the first group, the relationship between these variables is significant (r = 0.94, P < 0.001), and as the bloodless lung radioactivity increases, so does the lavage albumin. In saline controls or rabbits challenged 1 h before sacrifice, this relationship was not apparent. Meclofenamate treatment prevented an increase in lavage albumin without decreasing lung-associated albumin, implying there may still be interstitial accumulation in this circumstance without transit into the alveolus.
albumin did correlate with the increased lung/plasma ratio of '25I-RSA noted in rabbits receiving both CVF and hypoxia 4 h before death (r = 0.94, P < 0.001; Fig. 4 ). In addition, as shown in Fig. 5 , lung blood was noted to be significantly correlated with the radiolabeled albumin in the lavage for the control (saline injected) and experimental groups (CVF/hypoxia 1 and 4 h before sacrifice).
Effect of sodium meclofenamate treatment on lung injury produced by CVF plus hypoxia. One reason for selecting hypoxia as the second stimulus for challenge was the observation that hypoxia leads to generation of prostaglandins (14) . Therefore, in three experiments, meclofenamate was given before and after CVF/hypoxia as described above. This altered the response to CVF/hypoxia in several ways. First, Pao2 did not fall significantly from baseline values (data not shown), Other indices of lung function were not measured during these experiments because of simultaneous determinations of he- (Fig. 3) , and this was associated with a significant decrease in lavage neutrophils (P < 0.01, CVF/hypoxia vs. meclofenamate-CVF/hypoxia, Table I ). Meclofenamate did not, however, prevent the precipitous fall in circulating neutrophils after CVF. As shown in Fig. 4 , when meclofenamate was given with CVF/hypoxia, the lung/plasma ratio of '251-RSA could still be increased (compared with control animals) without an associated increase in the lavage/plasma ratio for albumin. Fig. 5 also shows that meclofenamate did not prevent the increase in lung blood found when CVF/hypoxia was given, but did prevent increases in lavage albumin.
Hemodynamic measurements. In six experiments where rabbits received CVF and hypoxia, pulmonary artery pressure (PAP) and cardiac output were monitored. In three experiments, the rabbits were also given meclofenamate whereas in the other three, only CVF/hypoxia was given. With CVF/hypoxia, the mean PAP was elevated from baseline values immediately after the bolus of CVF was given and again during the exposure to hypoxia (Fig. 6) Effect of CVF with and without hypoxia on lung structure.
The intravenous administration of CVF to rabbits caused neutrophil accumulation in the capillaries of the lung that was apparent on histologic examination of the lung 4 h after challenge. This histologic picture was indistinguishable from that seen after intravenous rabbit C5a as shown in a previous study (l1). Challenge with hypoxia alone did not cause any apparent abnormalities in light or electron microscopy during the same time period. With the combination of insults, the capillaries again contained many neutrophils, but in addition, the alveolar air spaces occasionally contained neutrophils. These differences between the histology of animals treated with CVF alone or CVF plus hypoxia were not striking on light microscopy. Examination by electron microscopy also revealed mild abnormalities. As shown in Fig. 7 , animals receiving CVF and hypoxia had distended vessels full of neutrophils and red blood cells (Fig. 7 a) with higher magnifications (Fig.  7 b) showing vesicles within endothelial cells. These findings were not as prominent in animals treated with either insult alone. No evidence of damage to alveolar epithelial-lining cells was noted in any group of animals. In addition, no evidence of intraalveolar or interstitial hemorrhage was found.
Discussion
This study demonstrates that complement activation with CVF, as an isolated challenge, does not lead to an increase in Cdy,,,) in this model. These observations are consistent with our earlier reported findings (11) , and further define the lack of physiologic effect of complement activation alone on the lung in the rabbit. In addition, however, we have shown that by combining complement activation with another challenge (hypoxia) that alone will not alter permeability or lung function, we can measureably alter lavage albumin, Pao2, RL, and Cdy,.
Recent reports have raised the possibility that complement activation with generation of C5-derived fragments will cause neutrophil deposition in the pulmonary vasculature and subsequent lung injury (29) . Whereas there is no question from experimental evidence that generation of complement-derived chemotactic fragments will cause sequestration of neutrophils within the lungs (1, 10, 11, 30) , it is possible that other stimuli may be needed in addition to complement activation for significant pulmonary alterations to occur (11, 13, 31) . For example, we recently noted that complement activation together with prostaglandin administration increased lung permeability to albumin in a rabbit model (13) . Based on these observations, it is possible to speculate that complement activation may play a part in acute lung injury by placing neutrophils in the target organ (lung), but other stimuli are needed to enhance their injurious potential.
For the present study, hypoxia was chosen as the second stimulus for two reasons. First, in shock lung syndrome, a disease where complement activation with pulmonary neutrophil sequestration has been implicated in its pathogenesis (2), hypoxia and/or poor tissue oxygenation are frequently found (32, 33) . Second, during hypoxia, prostaglandins are generated (14) , and as shown by Wedmore and Williams (12) plus Issekutz (34) in rabbit skin, and by our laboratory in rabbit lung (13) , the combination of a chemotactic agent with prostaglandins can lead to an increase in albumin accumulation in the target tissue. The timing of the hypoxic challenge was designed to occur at a time known from previous observations that the pulmonary vasculature contains many neutrophils (35) . The challenge was limited to 10 min because we found that although anesthetized rabbits could be maintained on 12% oxygen for up to 4 h with stable lung function and systemic blood pressure, the CVF stimulus followed by persistent 12% oxygen led to death of some animals over the time course of the experiments (Larsen, G. L., unpublished data). The periods of time chosen to assess permeability (0.5-1 h and 3.5-4 h after CVF) were deliberately separated from the challenges to avoid interference by hemodynamic events due to the stimuli that could have altered albumin accumulation in the lung due to pressure changes alone. As shown in Fig.  6 , the PAP was unchanged from baseline values during the time periods albumin accumulation was being measured.
The albumin accumulation in the lung lavage of animals treated with CVF and hypoxia, although statistically different from the other groups, varied greatly in magnitude. The differences in this value between experiments in this group were not readily apparent upon examining the data. The animals were not acidotic during the last 3.5 h of the experiment, and thus bradykinin production because of acidosis could not be implicated as a cause of the increased protein accumulation (36) . No obvious differences in neutrophil counts before or after challenge were noted among the animals, and the Pao2 upon exposure to 12% oxygen did not correlate with the albumin accumulation in the lavages. Despite this variability in albumin accumulation, this group was clearly different from the two other groups challenged with hypoxia alone or CVF alone in regard to lavage findings, Pao2, and lung mechanics. It is possible that slight alterations in the timing of the two events (CVF and hypoxia) could markedly increase or decrease these findings. This remains to be explored.
The lack of effect of intravenous CVF alone found in this study and a previous study (11) is in contrast to the results of Till et al. (10) and Ward and co-workers (37) . Several potential differences in the studies may explain these discrepancies. First, their experimental animal is the rat, and as reported by Martin and associates (38) , rat lung explants are more sensitive to oxidant injury than rabbit lung explants. Because oxygen radical production appears to be important in CVF-induced pulmonary changes (37) , the relative resistance of the lung of the rabbit to this injury may partially explain the differences in the studies. In addition, however, the definition of pulmonary alterations that signify injury is different. In the studies from Michigan (10, 37), altered permeability is defined through use of radiolabeled albumin or IgG injected intravenously. At sacrifice, the pulmonary vasculature was perfused free of blood, and the radioactivity remaining in the lung was determined and related to radioactivity in the blood. This measure of vascular permeability does not address whether the label is in the pulmonary interstitium (i.e., crossed the pulmonary endothelium) or in the alveolus (crossed both the pulmonary endothelium and epithelium). On the other hand, the primary marker of altered permeability to albumin used in this and our previous study (1 1) was lavage albumin. Thus, the radiolabeled protein had to traverse both barriers to be measured, making our assessment more stringent. In this study, delineation of the accumulation of interstitial protein was attempted by use of the two radiolabels (125I-RSA and 59Fe-RBC). Thus, the lung/plasma 125I-RSA represents both interstitial and lavage albumin whereas the lavage/plasma '251-RSA represents only lavageable albumin. As shown in Fig. 4 , in animals receiving CVF/hypoxia 4 h before death, a high correlation existed between the two measurements. It is important to note, however, that a high lung/plasma '25I-RSA was not always associated with a high lavage/plasma 1251I-RSA. For example, the highest lung/plasma 1251-RSA was in a meclofenamatetreated rabbit that received CVF/hypoxia, and yet lavage albumin was normal. For the meclofenamate group as a whole, the mean lung/plasma 1251I-RSA was greater than in controls, and yet lavage albumin was normal. This might imply that an arachidonic acid product of the cyclooxygenase pathway is necessary to allow albumin to cross this epithelial barrier. In addition, because meclofenamate will not block leukotriene production, it is possible that lipoxygenase products of arachidonic acid metabolism help mediate the interstitial accumulation of protein. These possibilities require more study.
The abolition of the albumin accumulation in animals made neutropenic before challenge implies that neutrophils are important in the development of this altered permeability. This finding is similar to the results recently reported by Heflin and Brigham (39) in chronically instrumented sheep, where neutrophil depletion prevented the increased lung vascular permeability to fluid and protein following endotoxin administration. Similar findings have been found in animal models of pulmonary edema associated with air emboli in sheep (40) and glass bead pulmonary embolization in dogs (41) . Thus, in this as in other models, the neutrophil may play an important role in altering vascular permeability in the lung. However, in our study as well as the ones cited above, it must be recognized that nitrogen mustard used as a neutrophil-depleting agent might have other effects on the lung. Neutrophil repletion experiments would make the argument stronger, but are presently technically difficult, and have the added drawback that infused cells are not functionally equivalent to normal neutrophils in vivo. These problems are being addressed in ongoing experiments so that improved techniques for reconstituting functional neutrophils will be available. In defense of the depletion studies, however, it is important to note that nitrogen mustard acts very rapidly on dividing cells, and was given 3 d before the experiments were conducted. The fact that the other hematologic parameters measured after this treatment were normal or near normal suggests the effects seen may be due to neutrophil depletion alone.
The effect of meclofenamate in various animal models of lung injury has differed. For example, in the sheep model of endotoxin-induced lung injury, Snapper and co-workers (42) found meclofenamate attenuated the early pulmonary hypertension after endotoxin infusion, but had no effect on the leukopenia induced by this insult. These results are similar to our finding. These authors note, however, that cyclooxygenase blocking agents do not significantly attenuate the late phase of increased permeability of the pulmonary vascular endothelium. Again, differences in animal models and definition of injury may explain what appear to be divergent results. In another sheep model of injury where the insult is repeated bolus injections of autologous zymosan activated plasma, Petrowski and associates (43) found meclofenamate inhibited hypoxemia but not the pulmonary hypertensive response or increased lymph flow and protein clearance. These results regarding the effect of meclofenamate on protein fluxes again are different, but may relate to our definition of permeability as an increase in lavage albumin although their measure is through assessment of protein in lymph. The fact that meclofenamate significantly decreased lavage albumin in our model while interstitial albumin remained high (lung/plasma '25I-RSA) would support that argument.
The mechanism through which meclofenamate (and the subsequent cyclooxygenase inhibition) work to decrease accumulation of albumin in the lavage is unknown. Because vasodilator prostaglandins such as prostaglandin '2 are produced during hypoxia, and could lead to a recruitment of pulmonary capillaries and/or an increase in capillary surface area, and this in itself might account for some of the increase in lavage albumin, the relative volume of blood in the lung was evaluated. As noted in Fig. 5 , there was a correlation between increases in lung blood and increases in lavage albumin. However, meclofenamate prevented increases in the latter variable while lung blood remained high, thus implying that cyclooxygenase products did not have their effect through an increase in capillary volume or surface area. It is interesting to note that meclofenamate treatment did prevent increases in neutrophils in the lavage of CVF/hypoxia-treated animals. Thus, its mechanism of action may relate to preventing neutrophil migration across the epithelial barrier. It is important to note that Issekutz (34) has reported vasodilating inflammatory mediators such as prostaglandins El and E2 enhanced neutrophil infiltration in rabbit skin in response to chemotactic stimuli. If a similar effect of chemotactic factors and prostaglandins occurs in the lung, then cyclooxygenase inhibition could decrease neutrophil emigration. This remains speculative at this point.
The pathophysiology of the changes in RL and Cdy,, remain to be explained. It is possible that these mild alterations are related to fluid and protein accumulation in the pulmonary interstitium and alveoli. The abrogation of these changes with neutrophil depletion and subsequent prevention of increased albumin flux would suggest this. However, it also is possible that mediators generated by the combined CVF/hypoxia stimuli might also mediate some or all of these changes. These possibilities remain to be explored.
This study has demonstrated complement activation with CVF in rabbits, as an isolated event, does not lead to measureable changes in lung function over a 4-h period, and does not lead to increased albumin accumulation across the lung at either an early or a late time point. The study does show, however, that by combining complement activation with a common physiologic event (hypoxia) that in itself does not harm the lung, we can induce measurable changes in lung structure and function.
